CD44 and neoplasm: A colony formation assay of both subpopulations showed that the number of colonies was significantly lower after Juglone treatment (Figure 5F), indicating that Juglone might be an effective inhibitor of CD44+CD133+ tumor-initiating Caco-2 cell-mediated tumorigenesis.